Filter Results
:
(141)
Show Results For
-
All HBS Web
(141)
- News (44)
- Research (87)
- Events (1)
- Multimedia (5)
- Faculty Publications (54)
Show Results For
-
All HBS Web
(141)
- News (44)
- Research (87)
- Events (1)
- Multimedia (5)
- Faculty Publications (54)
- 08 Mar 2021
- In Practice
COVID Killed the Traditional Workplace. What Should Companies Do Now?
A year ago, COVID-19 forced many companies to send employees home—often with a laptop and a prayer. Now, with COVID cases subsiding and vaccinations rising, the prospect of returning to old office routines appears more possible. But will employees want to flock back to...
View Details
Keywords:
by Dina Gerdeman
- 01 Dec 2023
- News
A More Accommodating Approach
Shelly Nooner (GMP 33, 2022) had already proven herself to be visionary and execution-focused during her two decades at Trimble, an industrial technology company that provides hardware, software, and services across agriculture, construction, geospatial, and...
View Details
Keywords:
Jennifer Gillespie
- Web
2023 Reunion Presentations - Alumni
biotech, Novartis CEO Vas Narasimhan mentioned that mentorship is a critical component of career success. This breakfast conversation will focus on how mentorship has positively benefitted both students and alumni. Guests include Jenny...
View Details
- Web
Credential of Leadership, Impact, and Management in Business | HBS Online
a high-stakes and uncertain world. Highlights Amy Edmondson, CLIMB Faculty Chair, Novartis Professor of Leadership and Management, Harvard Business School Introduction to Dynamic Teaming ShowHide Details Modules Psychological Safety...
View Details
- 29 Jan 2018
- Book
How 'Teaming' Saved 33 Lives in the Chilean Mining Disaster
is in process. Teaming, she says, is essential to organizational learning. In her new book Extreme Teaming: Lessons in Complex, Cross-Sector Leadership, Edmondson, the Novartis Professor of Leadership and Management at Harvard Business...
View Details
- 22 Mar 2021
- Research & Ideas
How to Learn from the Big Mistake You Almost Make
Edmondson, the Novartis Professor of Leadership and Management at Harvard Business School, and Olivia Jung, a doctoral student at HBS. Co-authors on the paper, which was published in The Joint Commission Journal on Quality and Patient...
View Details
- Blog
Leading in Tough Times: HBS Faculty Member Amy C. Edmondson on Psychological Safety
Amy C. Edmondson, Novartis Professor of Leadership and Management at Harvard Business School, has long studied the performance of teams in the workplace. Her latest book is The Fearless Organization: Creating Psychological Safety in the...
View Details
- Web
Published CSV Cases - Institute For Strategy And Competitiveness
management began drafting the company's sustainability plan for 2015 and beyond, CEO Andrew Liveris confronted the question of whether to maintain, modify or terminate the BWC program. SOCIAL BUSINESS AT NOVARTIS: AROGYA PARIVAR by Michael E. Porter, Mark R. Kramer,...
View Details
- Web
Past Issues - Alumni
Schumpeter Profiles from the class of 2007 Stepping Out Mission Possible Complete Table of Contents March 2007 Daniel Vasella Chairman and CEO of Novartis AG The Plight of the Global Poor Is it any business of business? Security Chief...
View Details
- 01 Sep 2023
- News
Research Brief: Making Way for Moonshots
Josh Krieger (Courtesy subject) Josh Krieger (Courtesy subject) Many innovations in modern medicine have come about due to cutting-edge drugs—advances that required both a scientific leap and a willingness to take risks. And while most pharmaceutical companies would...
View Details
Keywords:
Jen McFarland Flint
- Web
Recruiting Partners - Health Care
Hospital Nexeon MedSystems NextCare Urgent Care Northwestern Memorial Hospital Novartis International AG Novartis Vaccines and Diagnostics Novo Nordisk Pharmaceuticals, Inc. NP Medical Inc. O OmniGuide P...
View Details
- 12 Jun 2018
- Research & Ideas
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
was invented as a treatment for chronic myelogenous leukemia, and by the study’s measures was quite a novel drug. Novartis shares jumped almost 7 percent the day Gleevec was approved by the FDA. The drug proved effective and became a...
View Details
- Web
CSV in Practice - Institute For Strategy And Competitiveness
for Cisco customers, increasing industry growth. The program has also strengthened Cisco’s relationships with suppliers, customers and government. Integrating Strategy Across Levels - Novartis in Rural India Reconceiving Products &...
View Details
- Web
Faculty - Institute For Strategy And Competitiveness
Lasting Value. He serves on the board of directors of Exxon, Goldman Sachs, and Novartis and is chair of the Global Center for Leadership and Business Ethics. Profile Jay W. Lorsch, Louis Kirstein Professor of Human Relations Jay W....
View Details
- 01 Sep 2023
- News
Alumni and Faculty Books
Right Kind of Wrong: The Science of Failing Well By Amy C. Edmondson, Novartis Professor of Leadership and Management at Harvard Business School Atria Books We used to think of failure as the opposite of success. Now, we’re often torn...
View Details
- 16 Mar 2020
- Research & Ideas
How the Coronavirus Is Already Rewriting the Future of Business
quickly. The shift has happened in days, not months. Businesses may be able to learn how to move faster, acting in more agile ways, as a result. Amy C. Edmondson (@AmyCEdmondson) is the Novartis Professor of Leadership and Management....
View Details
Keywords:
by Dina Gerdeman
- 27 May 2015
- Research & Ideas
Build 'Scaffolds' to Improve Performance of Temporary Teams
"Four minutes," a triumphant Amy C. Edmondson exclaims as she arrives at her Harvard Business School office, clutching a bike helmet and explaining that her commute is 10 minutes faster by bicycle than by car. Edmondson, the View Details
- 13 Oct 2009
- Research & Ideas
7 Lessons for Navigating the Storm
focused strategy that builds off your unique strengths. Step 4: Make vital investments during the downturn. Intel and Exxon offer evidence that you cannot wait to make vital investments you need to win in the emerging market. When it appeared growth was slowing in the...
View Details
Keywords:
by Martha Lagace
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand the anguish of seriously ill...
View Details
- 01 Dec 2003
- News
Alumni Luminaries Discuss Careers, Values with HBS Students
Internal Revenue Service. Senior advisor, The Carlyle Group. He upgraded technology and information systems and stressed customer service in a dramatic turnaround of the IRS. Daniel L. Vasella, M.D. (PMD 57, 1989), chairman and CEO of View Details